Understanding Mounjaro Suitability Assessment

  • Comprehensive health evaluation examining medical history and current health status
  • Individual assessment criteria considering personal circumstances and treatment goals
  • Safety screening identifying potential contraindications or unsuitable conditions
  • Professional prescriber review ensuring treatment appropriateness and clinical oversight
Start free consultation

Treatment from £144.99

Takes under 2 minutes · 100% online
Person enjoying the outdoors

Check if you're eligible

Height 175 cm
Weight 82 kg
Your BMI
26.8
Check with prescriber
Start free consultation
Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.
100% UK-based pharmacy Free advice & support Rated Excellent 2,400+ reviews
Which route suits you

Two clinically backed paths to results

A weekly GLP-1 injection or a daily capsule — each fully overseen by our UK pharmacy team, with no obligation to continue.

Treatment
Avg. weight loss
05%10%15%20%25%
Availability
Injection
Weekly pen · GLP-1
Avg. weight loss
~20%up to
Availability Available now
Pill NEW
Daily tablet · Oral GLP-1
Avg. weight loss
~17%up to
Availability Explore now
Live Pricing

Our Range

Prices update live and may change. The live table below always takes precedence.
All treatment is subject to a prescriber consultation and clinical approval.

Who May Be Suitable for Mounjaro Treatment?

The Clinical Assessment Framework

Mounjaro suitability assessment follows a structured clinical framework designed to evaluate whether this prescription treatment may be appropriate for individual patients. UK-licensed prescribers conduct comprehensive reviews that examine multiple health factors, ensuring treatment decisions align with established clinical guidelines and patient safety requirements. The assessment process recognises that weight management treatments require careful consideration of individual circumstances, medical history, and potential treatment benefits versus risks.

Healthcare professionals conducting these assessments evaluate each patient's unique health profile, considering factors that may influence treatment suitability. This individualised approach ensures that Mounjaro may only be prescribed where clinically appropriate, following thorough evaluation by qualified prescribers. The assessment framework prioritises patient safety while identifying suitable candidates who may benefit from this prescription weight management treatment.

Clinical assessments incorporate evidence-based criteria that help prescribers determine treatment appropriateness. These evaluations consider both immediate suitability factors and longer-term treatment considerations, ensuring that prescribed treatments align with patients' overall health management goals. The structured approach helps maintain consistency in clinical decision-making while allowing for individualised treatment considerations.

Key Suitability Criteria and Considerations

Prescribers evaluate several key criteria when assessing Mounjaro suitability, beginning with overall health status and medical history review. This comprehensive evaluation examines existing health conditions, previous medical treatments, and current medication regimens to identify any factors that may influence treatment appropriateness. Healthcare professionals consider how potential treatment may interact with existing health management approaches and whether Mounjaro aligns with patients' broader health objectives.

Individual circumstances play a crucial role in suitability assessment, as prescribers recognise that effective weight management requires personalised approaches. Assessment criteria include evaluation of lifestyle factors, treatment motivation, and readiness to engage with comprehensive weight management programmes. Healthcare professionals assess whether patients understand the commitment required for effective treatment outcomes and can engage with necessary dietary and physical activity modifications.

Current health status evaluation forms a central component of suitability assessment, with prescribers examining factors that may influence treatment safety and effectiveness. This includes assessment of cardiovascular health, metabolic status, and any existing conditions that may require special consideration. Healthcare professionals evaluate whether patients' current health status supports safe treatment initiation and ongoing monitoring requirements.

Medical History and Safety Screening

Comprehensive medical history review constitutes a fundamental element of Mounjaro suitability assessment, enabling prescribers to identify factors that may influence treatment decisions. Healthcare professionals examine previous medical treatments, surgical history, and any ongoing health conditions that may affect treatment suitability. This thorough review helps identify potential contraindications or circumstances requiring additional clinical consideration before treatment decisions.

Safety screening protocols evaluate specific conditions and circumstances that may make Mounjaro treatment inappropriate for certain individuals. Prescribers assess factors including pregnancy status, breastfeeding, and plans for pregnancy, as Mounjaro is not recommended during these circumstances. Healthcare professionals also evaluate other medical conditions and medication interactions that may influence treatment safety or effectiveness.

Current medication review forms an essential component of safety screening, as prescribers must consider how Mounjaro may interact with existing treatments. Healthcare professionals evaluate all current medications, including prescription medicines, over-the-counter treatments, and supplements, to identify any potential interactions or contraindications. This comprehensive review ensures treatment decisions account for patients' complete medication profiles.

Mental health considerations also feature in suitability assessments, as effective weight management often requires psychological readiness and support. Prescribers may evaluate patients' mental health status and consider whether additional support services may be beneficial alongside medical treatment. This holistic approach recognises that successful weight management involves both physical and psychological components.

Individual Assessment Process and Clinical Decision-Making

Individual assessment processes recognise that Mounjaro suitability cannot be determined through standardised criteria alone, requiring personalised evaluation by qualified healthcare professionals. Prescribers conduct detailed consultations that explore patients' weight management history, previous treatment experiences, and specific health objectives. This individualised approach ensures treatment decisions reflect patients' unique circumstances and clinical needs.

Clinical decision-making incorporates professional judgment alongside established guidelines, enabling prescribers to make appropriate treatment recommendations based on comprehensive patient evaluation. Healthcare professionals consider multiple factors simultaneously, weighing potential treatment benefits against individual risk factors and contraindications. This balanced approach prioritises patient safety while identifying appropriate treatment candidates.

Treatment readiness assessment evaluates patients' understanding of Mounjaro treatment requirements and commitment to comprehensive weight management approaches. Prescribers assess whether patients understand that this prescription treatment supports rather than replaces lifestyle modifications, and whether they demonstrate readiness to engage with necessary dietary and physical activity changes. This evaluation helps predict treatment success and patient satisfaction with outcomes.

Follow-up and monitoring considerations also influence suitability decisions, as prescribers evaluate whether patients can engage with necessary ongoing clinical supervision. Healthcare professionals assess patients' availability for regular check-ins, monitoring appointments, and treatment adjustments as required. This ensures that prescribed treatments include appropriate clinical oversight throughout the treatment period.

Exclusions and Contraindications

Specific exclusions apply to Mounjaro prescribing, with certain conditions and circumstances making treatment inappropriate for some individuals. Pregnancy and breastfeeding represent absolute contraindications, as this treatment is not recommended during these circumstances. Healthcare professionals conduct thorough screening to identify these and other conditions that may preclude safe treatment initiation.

Age-related considerations form part of prescriber evaluation, as Mounjaro suitability assessment focuses on adult patients within appropriate age ranges. Healthcare professionals evaluate whether patients' age and developmental status support safe treatment use and effective weight management outcomes. This assessment considers both minimum age requirements and factors that may influence treatment appropriateness in different age groups.

Certain medical conditions may make Mounjaro treatment inappropriate, requiring careful evaluation by qualified healthcare professionals. Prescribers assess individual medical histories to identify conditions that may contraindicate treatment or require additional clinical consideration. This screening process ensures treatment decisions prioritise patient safety and clinical appropriateness.

Previous treatment experiences may also influence suitability assessment, as prescribers evaluate patients' responses to other weight management interventions. Healthcare professionals consider whether previous treatments provide insights into likely treatment success or identify factors requiring special attention. This comprehensive approach helps optimise treatment selection and patient outcomes.

NEW

GLP-1, now in adaily pill

Meet the daily GLP-1 tablet — needle-free, taken on your schedule, and prescribed by UK pharmacists. Designed for flexibility.

Join the free waitlist
Track your progress

Your journey,in your pocket

Track Now

Meet the newGLP-1 pill

  • Once-daily tablet · room-temp storage
  • No needles, no fridge
  • Up to ~15–17% in trials
How treatment works

How GLP-1 treatments help

Reduces appetite

Helps you feel fuller, sooner — so portions naturally shrink.

Curbs cravings

Quietens food noise so snacking and cravings ease off.

Slows digestion

Food stays in your stomach longer, steadying hunger between meals.

Steady blood sugar

Supports more stable glucose levels through the day.

Is GLP-1 treatment right for you?

GLP-1 medicines are powerful and prescription-only for good reason. They suit many people very well — and they aren’t appropriate for everyone. Here’s a clear, honest picture before you decide.

You may be suitable

Criteria met
BMI of 30 or higher
BMI of 27+ with weight-related conditions
Struggled to lose weight with diet alone
Ready to pair with lifestyle changes

Speak to us first

Potential risk
Pregnant, trying to conceive, or breastfeeding
History of certain thyroid cancers
Certain pancreatic or digestive conditions
Under the age of 18

Ready to start your journey?

Track your progress

Your journey, in your pocket

Track your journey

Log every dose and watch your progress build.

Download now Free to download — takes a minute to set up. App Store and Google Play

AI Meal Tracking. Built for GLP-1 Appetites.

Point your camera at any meal and in 4–6 seconds it logs the calories, macros, weight, and fullness it expects.

Never miss a dose

A daily nudge keeps you on track.

How it works

Achieve your goals in just a few simple steps.

Step 1

Start Free Consultation

Select safe UK treatments. Quick answers.

Step 2

Review By Our Clinical Team

Our expert team will use your consultation as the basis of our recommendation and communicate with you.

Step 3

Get it delivered fast

We’ll deliver direct to you, as quickly as tomorrow.

Trusted by thousands

Real people, real change

Hannah M.
Lost 2 st 4 lb in a year

“The cravings that used to run my evenings just quietened down. Having a pharmacist to message made it feel safe.”

David O.
Lost 3 st in a year

“Discreet, simple and genuinely supportive. The dose steps were explained clearly every time.”

Priya S.
Lost 1 st 9 lb in a year

“I finally feel like food isn’t the loudest thing in my head. The delivery was always discreet and on time.”

Frequently asked questions